Innate immunity to malaria caused by Plasmodium falciparum

Clinical and Investigative Medicine

Volumn 25, Issue 6, 2002, Pages 262-272

  Smith, Todd G ^a   Ayi, Kodjo ^a   Serghides, Lena ^a   Mcallister, Caroline D ^a   Kain, Kevin C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE;

GENE MUTATION; HOST PARASITE INTERACTION; HUMAN; IMMUNITY; INFECTION CONTROL; MACROPHAGE; MALARIA; MALARIA CONTROL; MONOCYTE; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

ANIMALS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; IMMUNITY, NATURAL; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; SICKLE CELL TRAIT; THALASSEMIA;

EID: 0036992329     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Malaria, 1982-1997. Wkly Epidemiol Rec 1999;74:265-70.
2. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002;415:680-5.
3. Greenwood B, Mutabungwa T. Malaria in 2002. Nature 2002;415:670-2.
4. Ridley RG. Medical need, scientific opportunity and the drive for antimalaria drugs. Nature 2002;415:686-93.
5. Richie TL, Saul A. Progress and challenges for malaria vaccines. Nature 2002;415:694-701.
6. Siniscalco M, Bernini L, Filippi G, Latte B, Meera Khan P, Piomelli S, et al. Population genetics of haemoglobin variants, thalassaemia and G6PD deficiency, with particular reference to the malaria hypothesis. Bull World Health Organ 1966;34:379-93.
7. Trubowitz S, Mazek B. Plasmodium falciparum: phagocytosis by polymorphonuclear leukocytes. Science 1968;162:273-4.
8. Celada A, Cruchaud A, Perrin LH. Phagocytosis of Plasmodium falciparum - parasitized erythrocytes by human polymorphonuclear leukocytes. J Parasitol 1983;69:49-53.
9. Ferrante A, Kumaratilake L, Rzepczyk CM, Dayer J-M. Killing of Plasmodium falciparum by cytokine-activated effector cells (neutrophils and macrophages). Immunol Lett 1990;25:179-88.
10. Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malaria pigment. J Exp Med 1992;177:1033-41.
11. Turrini F, Ginsburg H, Bussolino F, Pescarmona GP, Serra MV, Arese P. Phagocytosis of Plasmodium falciparum-infected human red blood cells by human monocytes: involvement of immune and non-immune determinants and dependence on parasite developmental stage. Blood 1992;80:801-8.
12. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 1995;182:409-18.
13. McGilvray ID, Serghides L, Kapus A, Rotstein OD, Kain KC. Non-opsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitised erythrocytes: a role for CD36 in malarial clearance. Blood 2000;96:3231-40.
14. Serghides L, Kain KC. PPARγ-RXR agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNFα secretion by monocytes/macrophages. J Immunol 2001;166:6742-8.
15. Serghides L, Kain KC. Mechanism of protection induced by vitamin A in falciparum malaria. Lancet 2002;359:1404-6.
16. Smith TG, Serghides L, Patel SN, Febbraio M, Silverstein RL, Kain KC. CD36-mediated non-opsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum. Infect Immun. In press.
17. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002;415:673-9.
18. Deitsch KW, Wellems TE. Membrane modifications in erythrocytes parasitized by Plasmodium falciparum. Mol Biochem Parasitol 1996;76:1-10.
19. Baruch, DI, Gormley JA, Ma C, Howard RJ, Pasloske BL. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intracellular adhesion molecule 1. Proc Natl Acad Sci U S A 1996;93:3497-502.
20. Baruch DI, Ma XC, Singh HB, Bi X, Pasloske BL, Howard RJ. Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence. Blood 1997;90:3766-75.
21. Ockenhouse CF, Chulay JD. Plasmodium falciparum sequestration: OKM5 antigen (CD36) mediates cytoadherence of parasitized erythrocytes to a myelomonocytic cell line. J Infect Dis 1988;157:584-8.
22. Ockenhouse CF, Magowan C, Chulay JD. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest 1989;84:468-75.
23. Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 1989;58:95-101.
24. Berendt AR, Simmons D, Tansey J, Newbold CK, Marsh K. Intercellular adhesion molecule 1 (ICAM-1) is an endothelial cytoadherence receptor for Plasmodium falciparum. Nature 1989;341:57-9.
25. Ockenhouse CF, Ho M, Tandon NN, Van Seventer GA, Shaw S, White NJ, et al. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 1991;164:163-9.
26. Treutiger CJ, Heddini A, Fernandez V, Muller WA, Wahlgren M. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nat Med 1997;3:1405-8.
27. Roberts DD, Sherwood JA, Spitalnik SL, Panton LJ, Howard RJ, Dixit VM, et al. Thrombospondin binds falciparum parasitized erythrocytes and may mediate cytoadherence. Nature 1985;318:64-6.
28. 3 on human microvascular endothelial cells. Am J Trop Med Hyg 1998;59:77-9.
29. Chiayaroj SC, Angkasekwinai P, Buranakiti A, Looareesuwan S, Rogerson SJ, Brown GV. Cytoadherence characteristics of Plasmodium falciparum isolates from Thailand: evidence for chondroitin sulfate as a cytoadherence receptor. Am J Trop Med Hyg 1996;55:76-80.
30. Beeson JG, Rogerson SJ, Cooke BM, Reeder JC, Chai W, Lawson AM, et al. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nature Med 2000;6:86-90.
31. Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ, Tachado SD. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 1996;156:1886-96.
32. Clark IA, Schofield L. Pathogenesis of malaria. Parasitol Today 2000;16:451-4.
33. Brown H, Turner G, Rogerson S, Tembo M, Mwenechanya J, Molyneux M, et al. Cytokine expression in the brain in human cerebral malaria. J Infect Dis 1999;180:1742-6.
34. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, et al. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria. J Infect Dis 1999;180:1288-97.
35. Dobbie MS, Hurst RD, Klein NJ, Surtees RA. Upregulation of intercellular adhesion molecule-1 expression on human endothelial cells by tumour necrosis factor-α in an in vitro model of the blood-brain barrier. Brain Res 1999;830:330-6.
36. Ricke CH, Staalsoe T, Koram K, Akanmori BD, Riley EM, Theander TG, et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J Immunol 2000;165:3309-16.
37. Nagel RL. Innate resistance to malaria: the intraerythrocytic cycle. Blood Cells 1990;16:321-39.
38. Metchnikoff E. Immunity in infective diseases (Translated by Binnie FG). Cambridge: Cambridge University Press; 1905. Reprint: The sources of science. No. 61. New York: Johnson Reprint Corporation; 1968.
39. Ehrlich P. Collected studies in immunity. New York: John Wiley and Sons; 1905.
40. Allison AC, Eugui EM. The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress. Ann Rev Immunol 1983;1:361-92.
41. Clark IA. Cell-mediated immunity in protection and pathology of malaria. Parasitol Today 1987;3:300-5.
42. Clark IA, Chaudhri G, Cowden WB. Some roles of free radicals in malaria. Free Radic Biol Med 1989;6:315-21.
43. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990;172:1633-41.
44. Bolad A, Berzins K. Antigenic diversity of Plasmodium falciparum and antibody-mediated parasite neutralization. Scand J Immunol 2000;52:233-9.
45. Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfelt JA, Peterson DS, et al. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 1995;82:89-99.
46. Chen Q, Fernandez V, Sundström A, Schlichtherle M, Sahlén A, Carlson J, et al. Developmental selection of var gene expression in Plasmodium falciparum. Nature 1998;394:392-5.
47. Newbold CI, Pinches R, Roberts DJ, Marsh K. Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Am J Trop Med Hyg 1997;57:389-98.
48. Facer CA. Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. II. Specificity of erythrocyte-bound IgG. Clin Exp Immunol 1980;39:279-88.
49. Mendis KN, David PH, Hommel M, Carter R, Miller LH. Immunity to malarial antigens on the surface of Plasmodium falciparum-infected erythrocytes. Am J Trop Med Hyg 1983;32:926-30.
50. Abdalla SH. Red cell associated IgG in patients suffering from Plasmodium falciparum malaria. Br J Haematol 1986;62:13-9.
51. Ho M, Webster HK. Immunology of human malaria. A cellular perspective. Parasite Immunol 1989;11:105-16.
52. Ho M, White NJ, Looareesuwan S, Wattanagoon Y, Lee SH, Walport MJ, et al. Splenic Fc-receptor function in host defense and anemia in acute Plasmodium falciparum malaria. J Infect Dis 1990;161:555-61.
53. Taliaferro WH, Mulligan HW. The histopathology of malaria with special reference to the function and origin of macrophages in defence. Ind Med Res Mem 1937;29:1.
54. Vernes A. Phagocytosis of Plasmodium falciparum parasitized erythrocytes by peripheral monocytes. Lancet 1980;2:1297-8.
55. Celada A, Cruchaud A, Perrin LH. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin Exp Immunol 1982;47:635-44.
56. Brown AE, Webster HK, Teja-Isavadharm P, Keeratithakul D. Macrophage activation in falciparum malaria as measured by neopterin and interferon-gamma. Clin Exp Immunol 1990;82:97-101.
57. Yuthavong Y, Bunyaratvej A, Kamchonwongpaisan S. Increased susceptibility of malaria-infected variant erythrocytes to the mononuclear phagocyte system. Blood Cells 1990;16:591-7.
58. Arese P, Turrini F, Ginsburg H. Erythrophagocytosis in malaria: Host defence or menace to the macrophage? Parasitol Today 1991;7:25-8.
59. Paul BB, Strauss RR, Jacobs AA, Sbarra AJ. Direct involvement of NADPH oxidase with the stimulated respiratory and hexose monophosphate shunt activities in phagocytizing leukocytes. Exp Cell Res 1972;73:456-62.
60. Arese P, Mannu F, Megow D, Turrini F. Band 3 and erythrocyte removal. In: Bamberg E, Passaw H, editors. The band 3 proteins: anion transporters, binding proteins and senescent antigens. Amsterdam: Elsevier; 1992. p. 229.
61. Sherman IW, Crandall I, Smith H. Membrane proteins involved in the adherence of Plasmodium falciparum-infected erythrocytes to the endothelium. Biol Cell 1992;74:161-78.
62. Giribaldi G, Ulliers D, Mannu F, Arese P, Turrini F. Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes. Br J Haematol 2001;113:492-9.
63. Haldane JB. The rate of mutation of human genes. Hereditas 1949;35:267-73.
64. Wilkinson RJ, Pasvol GP. Host resistance to malaria runs into swampy water. Trends Microbiol 1997;5:213-5.
65. Cappadoro M, Giribaldi G, O'Brien E, Turrini F, Mannu F, Ulliers D, et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998;92:2527-34.
66. Beutler E. G6PD deficiency [review]. Blood 1994;84:3613-36.
67. Ruwende C, Kloo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta A, et al. Natural protection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995;376:246-9.
68. Ruwende C, Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med 1998;76:581-8.
69. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 2001;293:455-62.
70. Williams TN, Weatherall DJ, Newbold CI. The membrane characteristics of Plasmodium falciparum-infected and -uninfected heterozygous α(0)thalassaemic erythrocytes. Br J Haematol 2002;118:663-70.
71. Luzzi GA, Torii M, Aikawa M, Pasvol G. Unrestricted growth of Plasmodium falciparum in microcytic erythrocytes in iron deficiency and thalassaemia. Br J Haematol 1990;74:519-24.
72. Senok AC, Li K, Nelson EA, Yu LM, Tian LP, Oppenheimer SJ. Invasion and growth of Plasmodium falciparum is inhibited in fractionated thalassaemic erythrocytes. Trans R Soc Trop Med Hyg 1997;91:138-43.
73. Pattanapanyasat K, Yongvanitchit K, Tongtawe P, Tachavanich K, Wanachiwanawin W, Fucharoen S, et al. Impairment of Plasmodium falciparum growth in thalassemic red blood cells: further evidence by using biotin labeling and flow cytometry. Blood 1999;93:3116-9.
74. Friedman MJ. Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci U S A 1978;75:1994-7.
75. Storey J, Fleming AF, Cornille-Brogger R, Molineaux L, Matsushima T, Kagan I. Abnormal haemoglobins in the Sudan savanna of Nigeria. IV. Malaria, immunoglobins and antimalarial antibodies in haemoglobin AC individuals. Ann Trop Med Parasitol 1979;73:311-5.
76. Friedman MJ. Oxidant damage mediates variant red cell resistance to malaria. Nature 1979;280:245-7.
77. Olson JA, Nagel RL. Synchonized cultures of P. falciparum in abnormal red cells: the mechanism of the inhibition of growth in HbCC cells. Blood 1986;67:997-1001.
78. Modiano D, Luoni G, Sirima BS, Simporé J, Verra F, Konaté A, et al. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 2001;414:305-8.
79. Bunyaratvej A, Butthep P, Yuthavong Y, Fucharoen S, Khusmith S, Yoksan S, et al. Increased phagocytosis of Plasmodium falciparum infected erythrocytes with haemoglobin E by peripheral blood monocytes. Acta Haematol 1986;76:155-8.
80. Hutagalung R, Wilairatana P, Looareesuwan S, Brittenham GM, Aikawa M, Gordeuk VR. Influence of hemoglobin E trait on the severity of Falciparum malaria. J Infect Dis 1999;179:283-6.
81. Cornille-Brogger R, Fleming AF, Kagan I, Matsushima T, Molineaux L. Abnormal haemoglobins in the Sudan savanna of Nigeria. II. Immunological response to malaria in normals and subjects with sickle cell trait. Ann Trop Med Parasitol 1979;73:173-83.
82. Luzzato L, Sodeinde O, Martini G. Genetic variation in the host and adaptive phenomena in Plasmodium falciparum infection. In: Malaria and the red cell Ciba Foundation Symposium No. 94. London: Pitman; 1983. p. 159.
83. Roth EF, Raventos-Suarez C, Rinaldi A, Nagel RL. Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc Natl Acad Sci U S A 1983;80:298-9.
84. Pasvol G, Wilson RJ. The interaction of malaria parasites with red blood cells. Br Med Bull 1982;38:133-40.
85. Golenser J, Miller J, Spira DT, Kosower NS, Vande Waa JA, Jensen JB. Inhibition of intraerythrocytic development of Plasmodium falciparum in glucose-6-phosphate dehydrogenase deficient erythrocytes is enhanced by oxidants and by crisis form factor. Trop Med Parasitol 1988;39:273-9.
86. O'Brien E, Kurdi-Haidar B, Wanachiwanawin W, Carvajal JL, Vulliamy T, Cappadoro M, et al. Cloning of the G-6-PD gene from Plasmodium falciparum. Mol Biochem Parasitol 1994;64:313-26.
87. Ayi K, Cappadoro M, Branca M, Turrini F, Arese P. Plasmodium falciparum glutathione metabolism and growth are independent of glutathione system of host erythrocyte. FEBS Lett 1998;424:257-61.
88. Martin SK. The malaria/G-6-PD hypothesis revisited. Parasitol Today 1994;10:251-2.
89. Luzzato L, Nwachaku-Jarrett ES, Reddy S. Increased sickling of parasitized erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet 1970;1:319-21.
90. Nagel RL, Roth EF. Malaria and red cell genetic defects. Blood 1989;74:1213-21.
91. Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Baudet AL, Sly WS, Valle D, editors: The metabolic basis of inherited disease. Vol. 2. 6th ed. New York: McGraw-Hill; 1989. p. 2281.
92. Ayi K. Enhanced phagocytic removal of early parasite forms: a novel mechanism of malaria protection in carriers of thalassaemia and sickle cell anaemia [thesis]. Torino, Italy: Department of Genetics, Biology and Biochemistry, University of Torino Medical School; 2000.
93. Knyszynski A, Danon D, Kahane I, Rachmilewitz EA. Phagocytosis of nucleated and mature beta-thalassaemic red blood cells by mouse macrophages in vitro. Br J Haematol 1979;43:251-5.
94. Luzzi GA, Merry AH, Newbold CI, Marsh K, Pasvol G, Weatherall DJ. Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in alpha- and beta-thalassemia. J Exp Med 1991;173:785-91.
95. Yuthavong Y, Wilairat P. Protection against malaria by thalassaemia and haemoglobin variants. Parasitol Today 1993;9:241-5.
96. Ruangjirachuporn W, Afzelius BA, Helmby H, Hill AV, Greenwood BM, Carlson J, et al. Ultrastructural analysis of fresh Plasmodium falciparum-infected erythrocytes and their cytoadherence to human leukocytes. Am J Trop Med Hyg 1992;46:511-9.
97. Staunton DE, Ockenhouse CF, Springer TA. Soluble intercellular adhesion molecule 1-immunoglobulin G1 immunoadhesin mediates phagocytosis of malaria-infected erythrocytes. J Exp Med 1992;176;1471-6.
98. Debets JM, Van der Linden CJ, Dieteren IE, Leeuwenberg JF, Buurman WA. Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol 1988;141:1197-201.
99. Debets JM, Van de Winkel JG, Ceuppens JL, Dieteren IE, Buurman WA. Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RI by treatment with proteases or neuraminidase. J Immunol 1990;144:1304-10.
100. Cooke BM, Nicoll CL, Baruch DI, Coppel RL. A recombinant peptide based on PfEMP-1 blocks and reverses adhesion of malaria-infected red blood cells to CD36 under flow. Mol Microbiol 1998;30:83-90.
101. Aikawa M, Iseki M, Barnwell JW, Taylor D, Oo MM, Howard RJ. The pathology of human cerebral malaria. Am J Trop Med Hyg 1990;43:30-7.
102. Turner GD, Morrison H, Jones M, Davis TM, Looareesuwan S, Buley ID, et al. An immunohistochemical study of the pathology of fatal malaria. Am J Pathol 1994;145:1057-69.
103. Newbold CI, Craig A, Kyes A, Rowe A, Fernandez-Reyes D, Fagan T. Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum. Int J Parasitol 1999;29:927-37.
104. Traore B, Muanza K, Looareesuwan S, Supavej S, Khusmith S, Danis M, et al. Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using in vitro human lung endothelial cells model. Am J Trop Med Hyg 2000;62:38-44.
105. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, Curtis BR, et al. Malaria susceptibility and CD36 mutation. Nature 2000;405:1015-7.
106. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998;93:241-52.
107. Shankar AH, Genton B, Semba RD, Baisor M, Paino J, Tamja S, et al. Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomized trial. Lancet 1999;354:203-9.